Carnitine palmitoyl transferase 1A deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

Carnitine palmitoyl transferase 1A deficiency

Synonyms: CPT1A deficiency | Carnitine palmitoyl transferase IA deficiency | Hepatic carnitine palmitoyl transferase 1 deficiency | Hepatic carnitine palmitoyl transferase I deficiency | L-CPT1 deficiency | L-CPTI deficiency

Carnitine palmitoyltransferase 1A (CPT-1A) deficiency is an inborn error of metabolism that affects mitochondrial oxidation of long chain fatty acids (LCFA) in the liver and kidneys and is characterized by recurrent attacks of fasting-induced hypoketotic hypoglycemia and risk of liver failure.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version April 2024

Newly diagnosed with
Carnitine palmitoyl transferase 1A deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Mississippi Metabolics Foundation

Our mission at Mississippi Metabolics Foundation (MMF) is to advocate, educate, and support families in MS affected by genetic metabolic disorders/inborn errors of metabolism (IEM's). MMF promotes initiatives and further advancements in legislation, education, research, clinical trials, studies, therapies, targeted treatments, and eventual cures for IEM’s and all rare diseases.

MitoAction

MitoAction’s mission is to improve the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, clinical research initiatives and by granting wishes for children affected by mitochondrial disease.

Clinical Trials

For a list of clinical trials in this disease area, please click here.